Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Virpax Pharmaceuticals stock
Learn how to easily invest in Virpax Pharmaceuticals stock.
Virpax Pharmaceuticals Inc is a biotechnology business based in the US. Virpax Pharmaceuticals shares (VRPX) are listed on the NASDAQ and all prices are listed in US Dollars. Virpax Pharmaceuticals employs 7 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Virpax Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VRPX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Virpax Pharmaceuticals stock price (NASDAQ: VRPX)Use our graph to track the performance of VRPX stocks over time.
Virpax Pharmaceuticals shares at a glance
|Latest market close||$1.16|
|52-week range||$1.10 - $5.62|
|50-day moving average||$1.40|
|200-day moving average||$1.94|
|Wall St. target price||$4.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.72|
Buy Virpax Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Virpax Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Virpax Pharmaceuticals price performance over time
|1 week (2022-09-23)||0.87%|
|1 month (2022-09-01)||-7.20%|
|3 months (2022-07-01)||-30.12%|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||-74.73%|
|2 years (2020-09-27)||N/A|
|3 years (2019-09-27)||N/A|
|5 years (2017-09-27)||N/A|
Virpax Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-56.38%|
|Return on equity TTM||-106.55%|
|Market capitalisation||$13.9 million|
TTM: trailing 12 months
Virpax Pharmaceuticals share dividends
We're not expecting Virpax Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Laboratory Corporation of America (LH.US) (1.36% forward annual dividend yield)
- Novartis AG ADR (NVS.US) (4.37% forward annual dividend yield)
Virpax Pharmaceuticals overview
Virpax Pharmaceuticals, Inc. , a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. .
Frequently asked questionsWhat percentage of Virpax Pharmaceuticals is owned by insiders or institutions?
Currently 25.739% of Virpax Pharmaceuticals shares are held by insiders and 15.933% by institutions. How many people work for Virpax Pharmaceuticals?
Latest data suggests 7 work at Virpax Pharmaceuticals. When does the fiscal year end for Virpax Pharmaceuticals?
Virpax Pharmaceuticals's fiscal year ends in December. Where is Virpax Pharmaceuticals based?
Virpax Pharmaceuticals's address is: 1055 Westlakes Drive, Berwyn, PA, United States, 19312 What is Virpax Pharmaceuticals's ISIN number?
Virpax Pharmaceuticals's international securities identification number is: US9282511073
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert